Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Wisconsin, Madison |
---|---|
Information provided by: | University of Wisconsin, Madison |
ClinicalTrials.gov Identifier: | NCT00819026 |
Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the genetics of this virus that might be important in order to treat it effectively.
Condition |
---|
Hepatitis C Virus |
Study Type: | Observational |
Study Design: | Cross-Sectional |
Ages Eligible for Study: | 18 Years to 70 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
solid organ transplant patients
Inclusion Criteria: - HCV infected on immunosuppression
United States, Wisconsin | |
University of Wisconsin | Recruiting |
Madison, Wisconsin, United States, 53706 | |
Contact: Rob Striker, MD/PhD 608-263-2994 rtstriker@wisc.edu | |
Principal Investigator: Rob Striker, MD/PhD |
Responsible Party: | university of Wisconsin ( Rob Striker, Assistant Professor of Medicine ) |
Study ID Numbers: | UWisHCV-1 |
Study First Received: | January 6, 2009 |
Last Updated: | January 7, 2009 |
ClinicalTrials.gov Identifier: | NCT00819026 History of Changes |
Health Authority: | United States: Federal Government |
Virus Diseases Hepatitis Liver Diseases |
Digestive System Diseases Hepatitis, Viral, Human Hepatitis C |
Virus Diseases Hepatitis RNA Virus Infections Liver Diseases |
Digestive System Diseases Flaviviridae Infections Hepatitis, Viral, Human Hepatitis C |